共 336 条
[1]
Thompson AR(2017)Targeting vascular remodeling to treat pulmonary arterial hypertension Trends Mol Med 23 31-45
[2]
Lawrie A(2006)Hypoxia- and non-hypoxia-related pulmonary hypertension—established and new therapies Cardiovasc Res 72 30-40
[3]
Ghofrani HA(2019)Pharmacotherapy for pulmonary arterial hypertension J Thorac Dis 11 S1767-299
[4]
Voswinckel R(2017)The cancer theory of pulmonary arterial hypertension Pulm Circ 7 285-130
[5]
Reichenberger F(2016)HIF-2α-mediated induction of pulmonary thrombospondin-1 contributes to hypoxia-driven vascular remodelling and vasoconstriction Cardiovasc Res 109 115-46
[6]
Weissmann N(2019)Inhibition of Src activation reverses pulmonary vascular remodeling in experimental pulmonary arterial hypertension via Akt/mTOR/HIF-1 signaling pathway Exp Cell Res 380 36-17
[7]
Schermuly RT(2019)CD146-HIF-1α hypoxic reprogramming drives vascular remodeling and pulmonary arterial hypertension Nat Commun 10 1-698
[8]
Seeger W(1992)Emodin, a protein tyrosine kinase inhibitor from Polygonum cuspidatum J Nat Prod 55 696-357
[9]
Grimminger F(2017)Emodin increases expression of insulin-like growth factor binding protein 1 through activation of MEK/ERK/AMPKα and interaction of PPARγ and Sp1 in lung cancer Cell Physiol Biochem 41 339-1572
[10]
Parikh V(2017)Emodin induces apoptosis of lung cancer cells through ER stress and the TRIB3/NF-κB pathway Oncol Rep 37 1565-1496